ISSN 1941-5923


Welcome to the American Journal of Case Reports

Clinical case reports are an invaluable first-hand source of evidence in medicine and a tool most often used in practice to exchange information and generate a more expanded search for evidence. In addition to the “evidence of what happened”, single or multiple cases are an important basis for further and more advanced research on diagnosis,  treatment effectiveness, causes and outcomes of disease. However limited their... read more

Published: 2015-03-01

POEMS Syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy and Skin Changes) Treated with Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review

Carlos Arana, José Antonio Pérez de León, Gerardo Gómez-Moreno, Ramón Pérez-Cano, Tomás Martín Hernández

(Endocrinology and Nutrition Clinical Administration Unit, Virgen Macarena University Hospital, Sevilla, Spain)

Am J Case Rep 2015; 16:124-129

DOI: 10.12659/AJCR.892837

Background: POEMS syndrome is a rare systemic pathology of paraneoplastic origin that is associated with plasma cell dyscrasia. It is characterized by the presence of sensorimotor polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes, and other systemic manifestations. The pathogenesis of the syndrome is unknown but over-production of vascular endothelial growth factor is probably responsible for most of the more characteristic symptoms.
There is no standard treatment for POEMS syndrome and no randomized controlled clinical trials of treatment exist in the available literature. High-dose melphalan with autologous hematopoietic stem cell transplantation should be considered for younger patients with widespread osteosclerotic lesions, and for patients with rapidly progressive neuropathy.
Case Report: This is the case of a 62-year-old Caucasian man who was admitted to our center presenting pretibial edema accompanied by significant weight loss and difficulty walking. POEMS criteria were present and an immunofixation test confirmed the presence of a monoclonal plasmaproliferative disorder. After autologous hematopoietic stem cell transplantation, the monoclonal component disappeared and the patient’s clinical status improved markedly.
Conclusions: Autologous hematopoietic stem cell transplantation following high-dose melphalan is an effective therapy for younger patients with widespread osteosclerotic lesions in POEMS syndrome.

Keywords: Paraproteinemias, POEMS Syndrome, Polyneuropathies, Transplantation, Autologous, Vascular Endothelial Growth Factor A

Related Articles (0)

Coming Soon...

Published: 2015-02-28

A Report of an Adult Case of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome, with a Review of 1...

Keiichiro Matsumoto, Kenichi Fukunari, Yuji Ikeda, Motoaki Miyazono, Tomoya Kishi, Ryoko Matsumoto, Makoto Fukuda, Saori Uchiumi, Mai Yoshizaki, Yasunori Nonaka, Akiko Kanaya

Am J Case Rep 2015; 16:119-123

DOI: 10.12659/AJCR.892788

Published: 2015-02-26

Inadvertent Transmission of Polycystic Kidney Disease in Kidney Transplantation

Amit Langote, Andrea Mazarova, John Mahoney, Brian Blew, Greg A. Knoll

Am J Case Rep 2015; 16:115-118

DOI: 10.12659/AJCR.892456